5 August 2022 in Journal of Invasive Cardiology
There are limited data on the association of operator volume with the outcomes of chronic total occlusion (CTO) percutaneous coronary intervention (PCI). We analyzed the association between operator volume and procedural outcomes of 7035 CTO-PCIs performed between 2012 and February 2021 at 30 centers. Original Contribution from Journal of Invasive Cardiology. Chronic Total Occlusion clinical outcomes operator volume percutaneous coronary intervention
1 June 2023 in Circulation: Cardiovascular Interventions
Background: Death is a rare but devastating complication of chronic total occlusion (CTO) percutaneous coronary intervention.Methods: We examined the clinical characteristics and procedural outcomes of patients who died periprocedurally in the Prospective Global Registry for the Study of CTO Interventions (PROGRESS-CTO).Results: Of the 12 928 patients who underwent CTO percutaneous coronary intervention between 2012 and 2022, 52 (0.4%) died during the index hospitalization. Patients who died were more likely to have a history of heart failure (43% versus 28%;P=0.023). The J-CTO ([Multicenter CTO Registry of Japan]; 2.8±1.1 versus 2.4±1.3;P=0.019), PROGRESS-CTO mortality (2.6±0.9 versus 1.6±1.1;P<0.001), and PROGRESS-CTO pericardiocentesis (2.9±1.1 versus 1.9±1.3;P<0.001) scores were higher in patients who died. In these patients, the use of left ventricular assist devices was also higher (41% versus 3.5%;P<0.001), and retrograde crossing was more often the first crossing strategy (33% versus 13%;P<0.001). The cause of death was cardiac in 43 patients (83%) and noncardiac in 9 patients (17%). Complications leading to cardiac death were: tamponade in 30 patients (58%), acute myocardial infarction in 9 (17.3%), and cardiac arrest/shock in 4 (7.7%). Noncardiac causes of death were: stroke in 3 (5.8%), renal failure in 2 (3.8%), respiratory distress in 2 (3.8%), and hemorrhagic shock in 2 (3.8%).Conclusions: Approximately 0.4% of patients who underwent CTO percutaneous coronary intervention died during the index hospitalization. The main cause of death was tamponade in 58%. PROGRESS-CTO complication scores might help in risk stratification and procedural planning in patients undergoing CTO percutaneous coronary intervention.Registration: URL:https://www.clinicaltrials.gov; Unique Identifier: NCT02061436.
23 November 2022 in Journal of Invasive Cardiology
Whether saphenous vein grafts (SVGs) should be occluded after successful chronic total occlusion (CTO) percutaneous coronary intervention (PCI) of the corresponding native vessel remains controversial. Original Contribution from Journal of Invasive Cardiology. Chronic Total Occlusion percutaneous coronary intervention Saphenous vein graft
8 December 2023 in Journal of Invasive Cardiology
We examined the clinical and angiographic characteristics and procedural outcomes of 8,788 CTO PCIs performed at 35 US and non-US centers between 2012 and 2022. In-hospital major adverse cardiac events (MACE) included death, myocardial infarction, urgent repeat target-vessel revascularization, tamponade requiring pericardiocentesis or surgery, and stroke. Original Contribution from Journal of Invasive Cardiology. Chronic Total Occlusion percutaneous coronary intervention ostial lesions
1 January 2023 in Journal of Invasive Cardiology
We examined guidewire and microcatheter utilization in 11,202 CTO-PCIs performed at 42 US and non-US centers.
12 August 2022 in Journal of Invasive Cardiology
The retrograde approach to coronary chronic total occlusions can be used as the initial crossing strategy (primary retrograde) or after failure of antegrade crossing attempts (secondary retrograde). Original Contribution from Journal of Invasive Cardiology. percutaneous coronary intervention Chronic Total Occlusion retrograde approach